NewslettersImmunology of Infectious Disease NewsUncategorizedPotent Prophylactic and Therapeutic Efficacy of Recombinant Human ACE2-FC against SARS-CoV-2 Infection In VivoBy Justin.choi - August 13, 2021013Scientists developed recombinant human ACE2-Fc fusion protein (hACE2-Fc) and a hACE2-Fc mutant with reduced catalytic activity.[Cell Discovery] 6445218 {6445218:NLCNGABM} apa 50 1 165650 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article